These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36388159)

  • 21. A four-hypoxia-genes-based prognostic signature for oral squamous cell carcinoma.
    Zhao C; Zhou Y; Ma H; Wang J; Guo H; Liu H
    BMC Oral Health; 2021 May; 21(1):232. PubMed ID: 33941139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a prognostic signature based on immune-related genes and the correlation with immune microenvironment in breast cancer.
    Dong M; Cui X; Wang G; Zhang Q; Li X
    Aging (Albany NY); 2022 Jul; 14(13):5427-5448. PubMed ID: 35793235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates.
    Fang Y; Liu J; Zhang Q; She C; Zheng R; Zhang R; Chen Z; Chen C; Wu J
    World J Surg Oncol; 2022 Jun; 20(1):211. PubMed ID: 35729567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Six CT83-related Genes-based Prognostic Signature for Lung Adenocarcinoma.
    Wang Y; Zhang G; Wang R
    Comb Chem High Throughput Screen; 2022; 25(9):1565-1575. PubMed ID: 34259140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of novel subtypes based on ssGSEA in immune-related prognostic signature for tongue squamous cell carcinoma.
    Jin Y; Wang Z; He D; Zhu Y; Chen X; Cao K
    Cancer Med; 2021 Dec; 10(23):8693-8707. PubMed ID: 34668665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Lung Adenocarcinoma.
    Huang H; Zhu G; Shi R; Li Y; Zhang Z; Xu S; Chen C; Cao P; Pan Z; Zhang H; Liu M; Liu H; Chen J
    J Cancer; 2022; 13(8):2631-2643. PubMed ID: 35711827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 17-gene expression-based prognostic signature associated with the prognosis of patients with breast cancer: A STROBE-compliant study.
    Qian JX; Yu M; Sun Z; Jiang AM; Long B
    Medicine (Baltimore); 2020 Apr; 99(15):e19255. PubMed ID: 32282693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel Framework to Predict Breast Cancer Prognosis Using Immune-Associated LncRNAs.
    Huang Z; Xiao C; Zhang F; Zhou Z; Yu L; Ye C; Huang W; Li N
    Front Genet; 2020; 11():634195. PubMed ID: 33584821
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification of a novel glycolysis-related signature to predict the prognosis of patients with breast cancer.
    He M; Hu C; Deng J; Ji H; Tian W
    World J Surg Oncol; 2021 Oct; 19(1):294. PubMed ID: 34600547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and validation of a ferroptosis-related gene signature predictive of prognosis in breast cancer.
    Liu Q; Ma JY; Wu G
    Aging (Albany NY); 2021 Sep; 13(17):21385-21399. PubMed ID: 34499616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in ER (+) and/or PR (+) and HER2 (-) Breast Cancer.
    Du F; Zheng F; Han Y; Zhao J; Yuan P
    Front Pharmacol; 2022; 13():820437. PubMed ID: 35721151
    [No Abstract]   [Full Text] [Related]  

  • 33. Identification of novel cell glycolysis related gene signature predicting survival in patients with breast cancer.
    Jiang F; Wu C; Wang M; Wei K; Wang J
    Sci Rep; 2021 Feb; 11(1):3986. PubMed ID: 33597614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel hypoxia- and lactate metabolism-related signature to predict prognosis and immunotherapy responses for breast cancer by integrating machine learning and bioinformatic analyses.
    Li J; Qiao H; Wu F; Sun S; Feng C; Li C; Yan W; Lv W; Wu H; Liu M; Chen X; Liu X; Wang W; Cai Y; Zhang Y; Zhou Z; Zhang Y; Zhang S
    Front Immunol; 2022; 13():998140. PubMed ID: 36275774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and verification of a hypoxia- and immune-associated prognosis signature for esophageal squamous cell carcinoma.
    Lian L; Teng SB; Xia YY; Shen XM; Zheng Y; Han SG; Wang WJ; Xu XF; Zhou C
    J Gastrointest Oncol; 2022 Apr; 13(2):462-477. PubMed ID: 35557566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Pyroptosis-Related Risk Genes APOBEC3D, TNFRSF14, and RAC2 Were Used to Evaluate Prognosis and as Tumor Suppressor Genes in Breast Cancer.
    Chen Q; Jun H; Yang C; Yang F; Xu Y
    J Oncol; 2022; 2022():3625790. PubMed ID: 36059808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a Hypoxia-Related Molecular Classification and Hypoxic Tumor Microenvironment Signature for Predicting the Prognosis of Patients with Triple-Negative Breast Cancer.
    Sun X; Luo H; Han C; Zhang Y; Yan C
    Front Oncol; 2021; 11():700062. PubMed ID: 34490098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel lactate metabolism-related signature predicts prognosis and tumor immune microenvironment of breast cancer.
    Zhang Z; Fang T; Lv Y
    Front Genet; 2022; 13():934830. PubMed ID: 36171887
    [No Abstract]   [Full Text] [Related]  

  • 39. Signature Based on Six Autophagy-related Genes to Predict Prognosis of Head and Neck Squamous Cell Carcinoma.
    Zhang H; Zhang L; Fan YT; Li TN; Peng LS; Wang KP; Ma J
    Curr Med Sci; 2022 Jun; 42(3):597-605. PubMed ID: 35648284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
    Wu JR; Zhao Y; Zhou XP; Qin X
    Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.